
STARTTOKENEVENT, BEFORE, DURING, EQUAL, FINISH, MEET, OVERLAP, START DATAMARKER
   
EVENTID-0,1;2;3;4;5;6;6, , , , , , 

EVENTID-6,1;2;3;4;5, , , , , , 

EVENTID-2,1;3;4;5, , , , , , 

EVENTID-5,1;3;3;4, , , , , , 

EVENTID-3,1;4, , , , , , 

EVENTID-1,4, , , , , , 

EVENTID-4, , , , , , , 
ENDTOKEN

All Event Descriptions:
=======================


EVENT-DESC-EVENT # 0 ==> 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID LEFT ARTERIOR DESCENDING ARTERY (LAD)
      		[Type = InitialDrugElutingStentImplantation][Computed Time Value = (Normalized Time= 2008)(Granularity=YEAR)(Computed As=ASSERTED)]
   
EVENT-DESC-EVENT # 6 ==> 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTHER LESION IN THE MID RIGHT CORONARY ARTERY (RCA).
      		[Type = FollowUpStentProcedure][Computed Time Value = Could not compute time from annotations!]
   
EVENT-DESC-EVENT # 2 ==> PT DEVELOPED BLEEDING IN THE GROIN
      		[Type = Complication_During_Surgery][Computed Time Value = Could not compute time from annotations!]
   
EVENT-DESC-EVENT # 5 ==> ASPIRIN AND CLOPIDOGREL WERE STOPPED
      		[Type = EndAntiplateletTherapy][Computed Time Value = Could not compute time from annotations!]
   
EVENT-DESC-EVENT # 3 ==> SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND ANGIOGRAM WAS DONE
      		[Type = Late_Stent_Thrombosis][Computed Time Value = Could not compute time from annotations!]
   
EVENT-DESC-EVENT # 1 ==> NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED IN THE RCA
      		[Type = FollowUpStentProcedure][Computed Time Value = Could not compute time from annotations!]
   
EVENT-DESC-EVENT # 4 ==> SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENSION AND BRADYCARDIA AND DIED
      		[Type = Patient_Death][Computed Time Value = Could not compute time from annotations!]
   

All Asserted and Inferred Relations:
====================================

EVENT-RELATION # 1: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS ...)
   
EVENT-RELATION # 2: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( PT DEVELOPED BLEEDING IN THE GROIN ...)
   
EVENT-RELATION # 3: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)
   
EVENT-RELATION # 4: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENS ...)
   
EVENT-RELATION # 5: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)
   
EVENT-RELATION # 6: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)
   
EVENT-RELATION # 7: ( 3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID  ...)==>[ BEFORE ]==>( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)
   
EVENT-RELATION # 8: ( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)==>[ BEFORE ]==>( NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS ...)
   
EVENT-RELATION # 9: ( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)==>[ BEFORE ]==>( PT DEVELOPED BLEEDING IN THE GROIN ...)
   
EVENT-RELATION # 10: ( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)==>[ BEFORE ]==>( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)
   
EVENT-RELATION # 11: ( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)==>[ BEFORE ]==>( SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENS ...)
   
EVENT-RELATION # 12: ( 2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTH ...)==>[ BEFORE ]==>( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)
   
EVENT-RELATION # 13: ( PT DEVELOPED BLEEDING IN THE GROIN ...)==>[ BEFORE ]==>( NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS ...)
   
EVENT-RELATION # 14: ( PT DEVELOPED BLEEDING IN THE GROIN ...)==>[ BEFORE ]==>( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)
   
EVENT-RELATION # 15: ( PT DEVELOPED BLEEDING IN THE GROIN ...)==>[ BEFORE ]==>( SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENS ...)
   
EVENT-RELATION # 16: ( PT DEVELOPED BLEEDING IN THE GROIN ...)==>[ BEFORE ]==>( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)
   
EVENT-RELATION # 17: ( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)==>[ BEFORE ]==>( NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS ...)
   
EVENT-RELATION # 18: ( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)==>[ BEFORE ]==>( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)
   
EVENT-RELATION # 19: ( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)==>[ BEFORE ]==>( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)
   
EVENT-RELATION # 20: ( ASPIRIN AND CLOPIDOGREL WERE STOPPED ...)==>[ BEFORE ]==>( SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENS ...)
   
EVENT-RELATION # 21: ( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)==>[ BEFORE ]==>( NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS ...)
   
EVENT-RELATION # 22: ( SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND  ...)==>[ BEFORE ]==>( SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENS ...)
   
EVENT-RELATION # 23: ( NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS ...)==>[ BEFORE ]==>( SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENS ...)
   
Timeline Buckets:
================

EVENT-TimeLineEntry # 1: {InitialDrugElutingStentImplantation [3.0X18MM XIENCE V STENT WAS DEPLOYED IN THE MID LEFT ARTERIOR DESCENDING ARTERY (LAD)]}
EVENT-TimeLineEntry # 2: {FollowUpStentProcedure [2.75X18MM XIENCE V STENT WAS USED TO TREAT ANOTHER LESION IN THE MID RIGHT CORONARY ARTERY (RCA).]}
EVENT-TimeLineEntry # 3: {Complication_During_Surgery [PT DEVELOPED BLEEDING IN THE GROIN]}
EVENT-TimeLineEntry # 4: {EndAntiplateletTherapy [ASPIRIN AND CLOPIDOGREL WERE STOPPED]}
EVENT-TimeLineEntry # 5: {Late_Stent_Thrombosis [SUSPICION OF IN-STENT THROMBOSIS OF THE RCA AND ANGIOGRAM WAS DONE]}
EVENT-TimeLineEntry # 6: {FollowUpStentProcedure [NEW PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED IN THE RCA]}
EVENT-TimeLineEntry # 7: {Patient_Death [SUBSEQUENTLY, THE PT DEVELOPED HYPOXIE, HYPOTENSION AND BRADYCARDIA AND DIED]}